Search

Displaying results 1231 - 1240 of 10000 in total
  1. Drug

    Sulfacetamide

    go.drugbank.com/drugs/DB00634
    Approved

    An anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.

    Mixtures: BRUMETON 1 MG/ML+100 MG/ML GÖZ DAMLASICategories: combinations of sulfonamides, Antiinfectives for Treatment of Acne
  2. Drug

    Tetrofosmin

    go.drugbank.com/drugs/DB11180
    Approved

    It presents a molecular formula of 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane. Tetrofosmin is part of the group of diphosphines. … Tetrofosmin was developed to overcome the non-target uptake of radioligands by the generation of hetero-atomic compounds.

    Mixtures: Tetrofosmin ROTOP 0,23 mg Kit für ein radioaktives ArzneimittelProducts: MYOVIEW FOR INJECTION 0.23 mg/vial
  3. Drug

    Potassium hydroxide

    go.drugbank.com/drugs/DB11153
    Approved

    Liquid drain cleaners contain 25 to 36% of potassium hydroxide [L1946]. … [L1946,L1951] This ingredient has been considered as generally safe as a direct human food ingredient by the FDA, based upon the observance of several good manufacturing practice conditions of use.

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Ofatumumab

    go.drugbank.com/drugs/DB06650
    ApprovedInvestigational

    In Phase III clinical trials consisting of subjects with relapsing forms of multiple sclerosis (RMS), subcutaneous administration of ofatumumab reduced the number of relapses and delayed disease progression … [L12753] The FDA subsequently approved ofatumumab for the treatment of RMS on August 20, 2020.

    Categories: CD20 (Clusters of Differentiation 20) inhibitorsProducts: ARZERRA 100 MG I.V. İNFÜZYONLUK ÇÖZELTİ KONSATRESİ İÇEREN FLAKON (3 ADET), ARZERRA 1000 MG I.V. İNFÜZYONLUK ÇÖZELTİ KONSATRESİ İÇEREN FLAKON (1 ADET)
  5. Drug

    Gefapixant

    go.drugbank.com/drugs/DB15097
    Approved

    [L48596,L48591] It is the first therapy to be approved for the treatment of RCC or UCC in the EU.[L48601] … or unexplained chronic cough (UCC) when no diagnosable cause for the cough can be determined.

    Categories: combinations of sulfonamides
  6. Drug

    Alicaforsen

    go.drugbank.com/drugs/DB06224
    Investigational

  7. Drug

    Gadopentetic acid

    go.drugbank.com/drugs/DB00789
    ApprovedInvestigational

    A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see pentetic acid), that is given to enhance the image in cranial and spinal MRIs.

    Categories: Diagnostic Uses of Chemicals, Compounds used in a research, industrial, or household settingProducts: MAGNEVIST INJECTION 469 mg/ml
  8. Drug

    Poa pratensis pollen

    go.drugbank.com/drugs/DB10366
    Approved

    Poa pratensis pollen is the pollen of the Poa pratensis plant. Poa pratensis pollen is mainly used in allergenic testing.

    Mixtures: Mixture of Six Standardized Grasses, Mixture of Four Standardized Grasses
  9. Drug

    Pyrimethamine

    go.drugbank.com/drugs/DB00205
    ApprovedInvestigationalVet approved

    One of the folic acid antagonists that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.

    Mixtures: SULFADOXINA 500 MG + PIRIMETAMINA 25 MG TABLETASProducts: DARAPRIM 25 MG TABLETAS
  10. Drug

    Ioversol

    go.drugbank.com/drugs/DB09134
    ApprovedInvestigational

    of internal structures. … [L41790] The intravascular administration of iodine compounds, such as ioversol, enhances the contrast between vessels in the path of the flow of the contrast medium and normal tissue, allowing the visualization

    Categories: Diagnostic Uses of Chemicals, Compounds used in a research, industrial, or household settingProducts: Optiray 240 mg J/ml - (nichtionische) parenterale Röntgenkontrastmittellösung, Optiray 300 mg J/ml - (nichtionische) parenterale Röntgenkontrastmittellösung